Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Wednesday, June 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Drug Patents

WASHINGTON - Mylan Pharmaceuticals cannot block an exclusive window that the Food and Drug Administration gave Teva Pharmaceuticals to sell a generic version of Cephalon's patented narcolepsy drug, Provigil (modafinil), a federal judge ruled.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.